From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Antibiotics and Bronchitis: Yet Another Failure

Azithromycin was no more effective than vitamin C in patients with acute bronchitis.

Acute bronchitis is one of the most commonly diagnosed diseases in the emergency department and is the cause of more than 10 million doctor visits every year. Most patients are prescribed antibiotics, despite concerns about growing antibiotic resistance and substantial evidence that antibiotics are ineffective for treating bronchitis. These authors evaluated the effectiveness of azithromycin for treating bronchitis in a multicenter, randomized, double-blind study.

Of 448 patients assessed for possible bronchitis (productive or nonproductive cough lasting for 2-14 days without evidence of pneumonia), 340 were diagnosed with bronchitis, and 220 met the criteria for randomization. Of the 189 patients who completed the study, 97 received 250 mg/day of azithromycin, and 92 received 250 mg/day of vitamin C. All patients also received dextromethorphan syrup and an albuterol inhaler to use every 6 hours as needed. Cough symptoms and limitations on activity were assessed at 3 and 7 days. No statistically significant differences between groups were identified. Although the authors had determined that 400 patients were needed to have sufficient statistical power to detect no difference in treatment between azithromycin and vitamin C, they stopped the study when a preliminary analysis indicated that it was unlikely that more patients would change the outcome.

Comment: What more do we need to hear? This is another of several studies demonstrating that antibiotics are not indicated for bronchitis, regardless of sputum production. ß2-agonists, such as albuterol, have been proven to reduce symptoms, and cough suppressants may improve patient comfort, but, except for these medications, keep that prescription pad in your pocket!

— James Scott, MD

Published in Journal Watch Emergency Medicine July 31, 2002

Citation(s):

Evans AT et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002 May 11; 359:1648-54.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2002. Massachusetts Medical Society. All rights reserved.